Norton Cancer Institute welcomes Kevin T. Breen, M.D., Ph.D., a physician-scientist who is dedicated to finding better treatments for one of the most challenging cancers: glioblastoma, an aggressive type of…
According to Mitchell Brooks, Norton Healthcare has saved his life not once, not twice, but three times. The 66-year-old man has faced cancer, cardiac emergencies and open heart surgery at…
Clinical trials play a vital role in discovering new cancer treatments. Each year, Norton Cancer Institute participates in numerous research studies that help develop better ways to treat cancer. Understanding…
Kendrick Thomas had found his niche at Bellarmine University — working toward a career that gave him the opportunity to follow in the footsteps of one of his greatest role…
Norton Cancer Institute is the first health care organization to dose a patient with a first-in-human Phase 1 clinical trial medication for treatment of solid tumors under the sponsorship of…
Norton Research Institute will expand research efforts with the unveiling of the new Norton Research Institute Clinical & Translational Research Laboratory. The 7,200-square-foot facility, located inside Norton Healthcare Pavilion in…
Norton Healthcare has expanded its research efforts with the creation of Norton Research Institute, the central entity overseeing all research throughout the organization, including clinical trials, across a multitude of…
Today Norton Healthcare announced an expansion of research efforts with the creation of Norton Research Institute, the central entity overseeing all research throughout the organization, including clinical trials, across a…
Norton Infectious Diseases Institute has been selected by Pfizer as the only site in United States to study how to effectively detect respiratory syncytial virus (RSV) in adults. “For the…
The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson &…
Norton Healthcare is one of the first in the nation to study convalescent plasma as a therapy to prevent high-risk patients with COVID-19, the disease caused by the coronavirus, from…
Renato V. LaRocca, M.D., values the opportunity to be at the forefront of brain cancer research. As a neuro-oncologist and cancer medicine specialist with Norton Cancer Institute, Dr. LaRocca has…